US Stock MarketDetailed Quotes

VERX Vertex

Watchlist

29.210
+0.080+0.27%

Close May 1 16:00 ET

29.210
0.0000.00%

Post 16:01 ET

4.53BMarket Cap-324555P/E (TTM)

Vertex Stock Forum

NASSER09

Apr 24 01:00

$Vertex(VERX.US)$ they buy with huge mony any news!!?

Moomoo AI

Mar 28 01:22

Vertex's leadership is excited about the acquisition of TriLogix, expecting it to enhance their commitment to providing top-notch construction project control services.

Press Release: The Vertex Companies, LLC Acquires TriLogix Consulting, LLC

Moomoo AI

Feb 12 20:07

Analysts predict Vertex to breakeven in less than a year, with an estimated yearly growth rate of 123%. If this rate is too optimistic, profitability may be delayed. The company's low debt reduces investment risk in the loss-making company.

Vertex, Inc. (NASDAQ:VERX) About To Shift From Loss To Profit

Moomoo AI

Jan 31 04:43

Analysts believe that if approved, VX-548 could generate over $5B in annual sales for Vertex. Despite the trials not showing superiority over opioids, the safety and addiction advantage of the drug is seen as a significant benefit.

Vertex Pharma Hits 52-week High on Addiction-free Pain Med

Moomoo AI

Dec 14, 2023 01:09

Analysts noted the effects of VX-548 appear comparable to 'gold standard' pain medicine pregabalin. Jefferies analysts stated the new data on the pain medicine 'looks at least as good as or better than investor expectations'.

Vertex's Stock Heads for All-time High as Non-opioid Painkiller Shows Promise

Moomoo AI

Dec 13, 2023 23:52

Analysts interpret the drug's trial data as a key derisking event for Vertex's stock, hinting at a potential blockbuster product. Concerns, however, are expressed over the absence of a placebo in the chronic neuropathic pain trial.

Vertex Stock Jumps on Hope for a Pain-Pill Blockbuster -- Barrons.com

Moomoo AI

Dec 9, 2023 01:06

Stifel analysts believe that the FDA's approval of exa-cel could significantly influence other Crispr-focused companies, potentially lessening risks for similar therapies, such as Editas Medicine's experimental cell therapy EDIT-301.

Crispr Therapeutics, Vertex Get FDA Approval for Breakthrough Gene-editing Treatment

淡定的惠特莫爾

Nov 22, 2023 02:14

The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics

$Direxion Daily S&P Biotech Bull 3x Shares ETF(LABU.US)$

Moomoo AI

Nov 18, 2023 02:33

Analysts fret over absence of placebo comparison in VX-548's trial design, causing uncertainty over its efficacy. The surprise revelation by COO precipitated a drastic dip in shares.

Vertex Shares Dip on Anxiety Over Pain Pill Trial -- Barrons.com

Moomoo AI

Nov 16, 2023 03:08

The decision by Vertex Pharmaceuticals for not including a placebo arm in the trial is pointed out as a point of concern by Leerink Partners Analyst David Risinger, indicating a potential negative impact on investor perception.

Vertex Pharma Drops Amid Concerns Over Trial Design for Pain Drug

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall